PDB Short entry for 1C5F HEADER ISOMERASE/IMMUNOSUPPRESSANT 22-NOV-99 1C5F TITLE CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI TITLE 2 COMPLEXED WITH CYCLOSPORIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE 1; COMPND 3 CHAIN: A, C, E, G, I, K, M, O; COMPND 4 FRAGMENT: CYCLOPHILIN-LIKE DOMAIN, RESIDUES 1-177; COMPND 5 SYNONYM: PPIASE 1, ROTAMASE, CYCLOPHILIN; COMPND 6 EC: 5.2.1.8; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CYCLOSPORIN A; COMPND 10 CHAIN: B, D, F, H, J, L, N, P; COMPND 11 SYNONYM: CYCLOSPORINE, CICLOSPORIN, CICLOSPORINE; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BRUGIA MALAYI; SOURCE 3 ORGANISM_TAXID: 6279; SOURCE 4 ATCC: 75593; SOURCE 5 GENE: BMCYP-1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ER2267; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: DOUBLE STRAND VECTOR (TAC, PMB1 AND SOURCE 10 AMPR); SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PMAL-C2; SOURCE 13 EXPRESSION_SYSTEM_GENE: MBP FUSION PROTEIN; SOURCE 14 MOL_ID: 2; SOURCE 15 SYNTHETIC: YES; SOURCE 16 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM; SOURCE 17 ORGANISM_TAXID: 29910 KEYWDS ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, CYCLOPHILIN-CYCLOSPORIN COMPLEX, KEYWDS 2 CYCLOSPORIN A, IMMUNOSUPPRESSANT, CYCLOPHILIN EXPDTA X-RAY DIFFRACTION AUTHOR P.J.ELLIS,C.K.S.CARLOW,D.MA,P.KUHN REVDAT 9 27-DEC-23 1C5F 1 REMARK LINK REVDAT 8 04-OCT-17 1C5F 1 REMARK REVDAT 7 27-JUL-11 1C5F 1 REMARK REVDAT 6 13-JUL-11 1C5F 1 VERSN REVDAT 5 24-FEB-09 1C5F 1 VERSN REVDAT 4 01-APR-03 1C5F 1 JRNL REVDAT 3 07-APR-00 1C5F 1 JRNL REVDAT 2 24-JAN-00 1C5F 1 JRNL REVDAT 1 03-DEC-99 1C5F 0 SPRSDE 02-DEC-99 1C5F 1QTL JRNL AUTH P.J.ELLIS,C.K.CARLOW,D.MA,P.KUHN JRNL TITL CRYSTAL STRUCTURE OF THE COMPLEX OF BRUGIA MALAYI JRNL TITL 2 CYCLOPHILIN AND CYCLOSPORIN A. JRNL REF BIOCHEMISTRY V. 39 592 2000 JRNL REFN ISSN 0006-2960 JRNL PMID 10642184 JRNL DOI 10.1021/BI991730Q REMARK 2 REMARK 2 RESOLUTION. 2.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.47 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 56200 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 2845 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.47 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.58 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 79.17 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5791 REMARK 3 BIN R VALUE (WORKING SET) : 0.3172 REMARK 3 BIN FREE R VALUE : 0.3733 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.92 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 285 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 11437 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 337 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -13.82300 REMARK 3 B22 (A**2) : 3.64800 REMARK 3 B33 (A**2) : 10.17500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 6.03800 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.320 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.220 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.030 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.820 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.640 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 31.56 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: USED MAXIMUM LIKELIHOOD TARGET BASED ON REMARK 3 STRUCTURE FACTORS WITH NO CUTOFFS REMARK 4 REMARK 4 1C5F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-NOV-99. REMARK 100 THE DEPOSITION ID IS D_1000001359. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JUL-98 REMARK 200 TEMPERATURE (KELVIN) : 105.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9800 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56200 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.470 REMARK 200 RESOLUTION RANGE LOW (A) : 47.140 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.47 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 0.37200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, CALCIUM ACETATE, METHANOL, REMARK 280 MES, PH 6.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.08000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7, 8 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8420 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: M, N REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 8 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: O, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 THE CYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF IMMUNOSUPPRESSANT REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: B, D, F, H, J, L, N, P REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION REMARK 400 IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET E 1 REMARK 465 SER E 2 REMARK 465 LYS E 3 REMARK 465 MET G 1 REMARK 465 SER G 2 REMARK 465 LYS G 3 REMARK 465 LYS G 4 REMARK 465 ASP G 5 REMARK 465 MET I 1 REMARK 465 SER I 2 REMARK 465 LYS I 3 REMARK 465 LYS I 4 REMARK 465 MET K 1 REMARK 465 SER K 2 REMARK 465 MET M 1 REMARK 465 SER M 2 REMARK 465 MET O 1 REMARK 465 SER O 2 REMARK 465 LYS O 3 REMARK 465 LYS O 4 REMARK 465 ASP O 5 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 51 CG CD CE NZ REMARK 480 ILE A 68 CD1 REMARK 480 ILE A 136 CG1 CG2 CD1 REMARK 480 LYS A 157 NZ REMARK 480 LYS C 4 CB CG CD CE NZ REMARK 480 LYS C 80 NZ REMARK 480 LYS E 4 CE NZ REMARK 480 ILE E 136 CG1 CG2 CD1 REMARK 480 MLE F 8 CD1 CD2 REMARK 480 ILE G 136 CG1 CG2 CD1 REMARK 480 ASP I 5 C O CB CG OD1 OD2 REMARK 480 SER I 53 OG REMARK 480 MET I 93 CE REMARK 480 VAL I 144 CG1 CG2 REMARK 480 MLE J 8 CD1 CD2 REMARK 480 SER K 53 CB OG REMARK 480 LYS K 60 NZ REMARK 480 SER M 62 OG REMARK 480 SER M 160 OG REMARK 480 LYS M 161 CE NZ REMARK 480 LYS O 102 CE NZ REMARK 480 LYS O 161 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 28 77.40 -105.90 REMARK 500 ALA A 32 60.11 -153.08 REMARK 500 PHE A 71 -80.03 -134.24 REMARK 500 HIS A 103 46.86 -95.80 REMARK 500 LYS A 114 52.05 -140.39 REMARK 500 ASN A 117 62.46 38.23 REMARK 500 ASN A 135 -5.86 71.26 REMARK 500 PHE C 71 -73.58 -122.25 REMARK 500 ASP C 95 176.88 -59.84 REMARK 500 HIS C 103 34.53 -90.27 REMARK 500 PHE C 107 34.43 71.98 REMARK 500 LYS C 114 47.53 -146.88 REMARK 500 ALA C 130 56.61 -142.46 REMARK 500 ILE C 136 -11.20 -146.36 REMARK 500 ASN E 70 18.38 58.72 REMARK 500 PHE E 71 -71.09 -131.94 REMARK 500 HIS E 103 48.83 -87.06 REMARK 500 THR E 127 15.31 -142.88 REMARK 500 ASP E 167 95.95 -67.30 REMARK 500 ASP G 30 -4.07 -58.37 REMARK 500 PHE G 71 -79.25 -144.51 REMARK 500 GLU G 97 -169.42 -74.67 REMARK 500 ASN G 117 41.55 39.44 REMARK 500 PHE I 71 -74.10 -127.14 REMARK 500 LYS I 80 -27.37 -141.58 REMARK 500 HIS I 103 36.44 -94.85 REMARK 500 ASN I 113 -159.45 -164.70 REMARK 500 LYS I 114 27.94 -151.27 REMARK 500 THR I 118 32.45 -141.56 REMARK 500 ALA I 130 57.82 -146.40 REMARK 500 PHE K 71 -79.37 -135.42 REMARK 500 ASP K 82 6.32 -151.11 REMARK 500 PHE K 99 65.37 -69.51 REMARK 500 ALA K 130 55.18 -142.24 REMARK 500 ASN K 135 -6.65 69.00 REMARK 500 ABA L 6 77.41 -118.79 REMARK 500 ILE M 52 -84.06 -71.54 REMARK 500 SER M 62 -177.37 -61.70 REMARK 500 PHE M 71 -82.20 -120.03 REMARK 500 HIS M 103 41.80 -98.61 REMARK 500 LYS M 114 43.65 -147.78 REMARK 500 ALA M 130 52.03 -144.66 REMARK 500 PRO M 131 -16.23 -47.29 REMARK 500 ILE M 136 -1.56 -145.51 REMARK 500 ASN M 159 -169.92 -103.35 REMARK 500 ASN M 162 20.55 85.94 REMARK 500 PHE O 71 -82.30 -129.92 REMARK 500 ASP O 82 16.64 -140.07 REMARK 500 HIS O 103 56.78 -96.52 REMARK 500 PHE O 107 41.28 70.95 REMARK 500 REMARK 500 THIS ENTRY HAS 51 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN H OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN J OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN L OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN N OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN P OF CYCLOSPORIN A REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 C REMARK 900 RELATED ID: 1CSA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1CWA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 1CWB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 1CWC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 D REMARK 900 RELATED ID: 1CWH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A MODIFIED AT POSITION 7 REMARK 900 RELATED ID: 1CWI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITION 7 REMARK 900 RELATED ID: 1CWJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH NODIFIED REMARK 900 CYCLOSPORIN C AT POSITIONS 1, AND 9 REMARK 900 RELATED ID: 1CYA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WIYH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYB RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1IKF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CTCLOSPORIN-FAB COMPLEX REMARK 900 RELATED ID: 1M63 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN COMPLEX REMARK 900 RELATED ID: 1MF8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH HUMAN REMARK 900 CYCLOPHILIN AND CYCLOSPORIN A REMARK 900 RELATED ID: 1MIK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 6 REMARK 900 RELATED ID: 1QNG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED REMARK 900 WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1QNH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE REMARK 900 MUTANT) COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1XQ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2ESL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2OJU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN J COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2POY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II CYCLOPHILIN A REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2RMA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2RMB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 2RMC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2WFJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN G REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2X2C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2X7K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PPIL1 COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2Z6W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3BO7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOSPHILIN A FROM TOXOPLASMA GONDII REMARK 900 COMPLEXED WIT CYCLOSPORIN A REMARK 900 RELATED ID: 3CYS RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3EOV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI COMPLEXED REMARK 900 WITH CYCLOSPORIN A DBREF 1C5F A 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1C5F B 1 11 NOR NOR00033 NOR00033 1 11 DBREF 1C5F C 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1C5F D 1 11 NOR NOR00033 NOR00033 1 11 DBREF 1C5F E 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1C5F F 1 11 NOR NOR00033 NOR00033 1 11 DBREF 1C5F G 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1C5F H 1 11 NOR NOR00033 NOR00033 1 11 DBREF 1C5F I 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1C5F J 1 11 NOR NOR00033 NOR00033 1 11 DBREF 1C5F K 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1C5F L 1 11 NOR NOR00033 NOR00033 1 11 DBREF 1C5F M 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1C5F N 1 11 NOR NOR00033 NOR00033 1 11 DBREF 1C5F O 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1C5F P 1 11 NOR NOR00033 NOR00033 1 11 SEQRES 1 A 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 A 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 A 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 A 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 A 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 A 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 A 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 A 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 A 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 A 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 A 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 A 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 A 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 A 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 B 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 C 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 C 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 C 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 C 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 C 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 C 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 C 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 C 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 C 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 C 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 C 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 C 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 C 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 C 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 D 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 E 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 E 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 E 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 E 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 E 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 E 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 E 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 E 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 E 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 E 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 E 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 E 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 E 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 E 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 F 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 G 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 G 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 G 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 G 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 G 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 G 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 G 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 G 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 G 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 G 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 G 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 G 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 G 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 G 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 H 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 I 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 I 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 I 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 I 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 I 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 I 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 I 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 I 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 I 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 I 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 I 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 I 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 I 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 I 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 J 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 K 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 K 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 K 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 K 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 K 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 K 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 K 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 K 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 K 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 K 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 K 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 K 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 K 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 K 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 L 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 M 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 M 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 M 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 M 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 M 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 M 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 M 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 M 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 M 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 M 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 M 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 M 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 M 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 M 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 N 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 O 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 O 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 O 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 O 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 O 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 O 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 O 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 O 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 O 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 O 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 O 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 O 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 O 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 O 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 P 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA HET DAL B 1 5 HET MLE B 2 9 HET MLE B 3 9 HET MVA B 4 8 HET BMT B 5 13 HET ABA B 6 6 HET SAR B 7 5 HET MLE B 8 9 HET MLE B 10 9 HET DAL D 1 5 HET MLE D 2 9 HET MLE D 3 9 HET MVA D 4 8 HET BMT D 5 13 HET ABA D 6 6 HET SAR D 7 5 HET MLE D 8 9 HET MLE D 10 9 HET DAL F 1 5 HET MLE F 2 9 HET MLE F 3 9 HET MVA F 4 8 HET BMT F 5 13 HET ABA F 6 6 HET SAR F 7 5 HET MLE F 8 9 HET MLE F 10 9 HET DAL H 1 5 HET MLE H 2 9 HET MLE H 3 9 HET MVA H 4 8 HET BMT H 5 13 HET ABA H 6 6 HET SAR H 7 5 HET MLE H 8 9 HET MLE H 10 9 HET DAL J 1 5 HET MLE J 2 9 HET MLE J 3 9 HET MVA J 4 8 HET BMT J 5 13 HET ABA J 6 6 HET SAR J 7 5 HET MLE J 8 9 HET MLE J 10 9 HET DAL L 1 5 HET MLE L 2 9 HET MLE L 3 9 HET MVA L 4 8 HET BMT L 5 13 HET ABA L 6 6 HET SAR L 7 5 HET MLE L 8 9 HET MLE L 10 9 HET DAL N 1 5 HET MLE N 2 9 HET MLE N 3 9 HET MVA N 4 8 HET BMT N 5 13 HET ABA N 6 6 HET SAR N 7 5 HET MLE N 8 9 HET MLE N 10 9 HET DAL P 1 5 HET MLE P 2 9 HET MLE P 3 9 HET MVA P 4 8 HET BMT P 5 13 HET ABA P 6 6 HET SAR P 7 5 HET MLE P 8 9 HET MLE P 10 9 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE FORMUL 2 DAL 8(C3 H7 N O2) FORMUL 2 MLE 32(C7 H15 N O2) FORMUL 2 MVA 8(C6 H13 N O2) FORMUL 2 BMT 8(C10 H19 N O3) FORMUL 2 ABA 8(C4 H9 N O2) FORMUL 2 SAR 8(C3 H7 N O2) FORMUL 17 HOH *337(H2 O) HELIX 1 1 SER A 2 ARG A 6 5 5 HELIX 2 2 ALA A 32 GLY A 45 1 14 HELIX 3 3 ALA A 130 ASN A 134 5 5 HELIX 4 4 GLY A 146 TYR A 155 1 10 HELIX 5 5 SER C 2 ARG C 6 5 5 HELIX 6 6 ALA C 32 GLY C 45 1 14 HELIX 7 7 ALA C 130 ASN C 134 5 5 HELIX 8 8 GLY C 146 TYR C 155 1 10 HELIX 9 9 ALA E 32 GLY E 45 1 14 HELIX 10 10 ALA E 130 ASN E 134 5 5 HELIX 11 11 GLY E 146 TYR E 155 1 10 HELIX 12 12 ALA G 32 GLY G 45 1 14 HELIX 13 13 ALA G 130 ASN G 134 5 5 HELIX 14 14 GLY G 146 TYR G 155 1 10 HELIX 15 15 ALA I 32 GLY I 45 1 14 HELIX 16 16 ALA I 130 ASN I 134 5 5 HELIX 17 17 GLY I 146 TYR I 155 1 10 HELIX 18 18 ALA K 32 GLY K 45 1 14 HELIX 19 19 ALA K 130 ASN K 134 5 5 HELIX 20 20 GLY K 146 TYR K 155 1 10 HELIX 21 21 ALA M 32 GLY M 45 1 14 HELIX 22 22 ALA M 130 ASN M 134 5 5 HELIX 23 23 GLY M 146 TYR M 155 1 10 HELIX 24 24 ALA O 32 GLY O 45 1 14 HELIX 25 25 ALA O 130 ASN O 134 5 5 HELIX 26 26 GLY O 146 TYR O 155 1 10 SHEET 1 AA 8 ARG A 66 ILE A 68 0 SHEET 2 AA 8 MET A 72 GLY A 75 -1 O MET A 72 N ILE A 68 SHEET 3 AA 8 PHE A 123 THR A 126 -1 O PHE A 123 N GLY A 75 SHEET 4 AA 8 VAL A 108 MET A 111 -1 O VAL A 108 N THR A 126 SHEET 5 AA 8 VAL A 139 SER A 145 -1 N PHE A 140 O VAL A 109 SHEET 6 AA 8 ASN A 18 LEU A 27 -1 O VAL A 24 N VAL A 144 SHEET 7 AA 8 ARG A 8 ILE A 15 -1 O VAL A 9 N MET A 25 SHEET 8 AA 8 VAL A 168 GLU A 175 -1 O VAL A 169 N THR A 14 SHEET 1 CA 8 PHE C 64 ILE C 68 0 SHEET 2 CA 8 MET C 72 GLY C 75 -1 O MET C 72 N ILE C 68 SHEET 3 CA 8 PHE C 123 THR C 126 -1 O PHE C 123 N GLY C 75 SHEET 4 CA 8 VAL C 108 MET C 111 -1 O VAL C 108 N THR C 126 SHEET 5 CA 8 VAL C 139 SER C 145 -1 N PHE C 140 O VAL C 109 SHEET 6 CA 8 ASN C 18 LEU C 27 -1 O VAL C 24 N VAL C 144 SHEET 7 CA 8 ARG C 8 ILE C 15 -1 O VAL C 9 N MET C 25 SHEET 8 CA 8 VAL C 168 GLU C 175 -1 O VAL C 169 N THR C 14 SHEET 1 EA 8 PHE E 64 ILE E 68 0 SHEET 2 EA 8 MET E 72 GLY E 75 -1 O MET E 72 N ILE E 68 SHEET 3 EA 8 PHE E 123 THR E 126 -1 O PHE E 123 N GLY E 75 SHEET 4 EA 8 VAL E 108 MET E 111 -1 O VAL E 108 N THR E 126 SHEET 5 EA 8 VAL E 139 SER E 145 -1 N PHE E 140 O VAL E 109 SHEET 6 EA 8 ASN E 18 LEU E 27 -1 O VAL E 24 N VAL E 144 SHEET 7 EA 8 ARG E 7 ILE E 15 -1 O ARG E 7 N LEU E 27 SHEET 8 EA 8 VAL E 168 GLU E 175 -1 O VAL E 169 N THR E 14 SHEET 1 GA 8 ARG G 66 ILE G 68 0 SHEET 2 GA 8 MET G 72 GLY G 75 -1 O MET G 72 N ILE G 68 SHEET 3 GA 8 PHE G 123 THR G 126 -1 O PHE G 123 N GLY G 75 SHEET 4 GA 8 VAL G 108 MET G 111 -1 O VAL G 108 N THR G 126 SHEET 5 GA 8 VAL G 139 SER G 145 -1 N PHE G 140 O VAL G 109 SHEET 6 GA 8 ASN G 18 LEU G 27 -1 O VAL G 24 N VAL G 144 SHEET 7 GA 8 ARG G 7 ILE G 15 -1 O ARG G 7 N LEU G 27 SHEET 8 GA 8 VAL G 168 LEU G 176 -1 O VAL G 169 N THR G 14 SHEET 1 IA 8 ARG I 66 ILE I 68 0 SHEET 2 IA 8 MET I 72 GLY I 75 -1 O MET I 72 N ILE I 68 SHEET 3 IA 8 PHE I 123 THR I 126 -1 O PHE I 123 N GLY I 75 SHEET 4 IA 8 VAL I 108 MET I 111 -1 O VAL I 108 N THR I 126 SHEET 5 IA 8 VAL I 139 SER I 145 -1 N PHE I 140 O VAL I 109 SHEET 6 IA 8 ASN I 18 LEU I 27 -1 O VAL I 24 N VAL I 144 SHEET 7 IA 8 ARG I 8 ILE I 15 -1 O VAL I 9 N MET I 25 SHEET 8 IA 8 VAL I 168 GLU I 175 -1 O VAL I 169 N THR I 14 SHEET 1 KA 8 ARG K 66 ILE K 68 0 SHEET 2 KA 8 MET K 72 GLY K 75 -1 O MET K 72 N ILE K 68 SHEET 3 KA 8 PHE K 123 THR K 126 -1 O PHE K 123 N GLY K 75 SHEET 4 KA 8 VAL K 108 MET K 111 -1 O VAL K 108 N THR K 126 SHEET 5 KA 8 VAL K 139 SER K 145 -1 N PHE K 140 O VAL K 109 SHEET 6 KA 8 ASN K 18 LEU K 27 -1 O VAL K 24 N VAL K 144 SHEET 7 KA 8 ARG K 7 ILE K 15 -1 O ARG K 7 N LEU K 27 SHEET 8 KA 8 VAL K 168 GLU K 175 -1 O VAL K 169 N THR K 14 SHEET 1 MA 8 PHE M 64 ILE M 68 0 SHEET 2 MA 8 MET M 72 GLY M 75 -1 O MET M 72 N ILE M 68 SHEET 3 MA 8 PHE M 123 THR M 126 -1 O PHE M 123 N GLY M 75 SHEET 4 MA 8 VAL M 108 MET M 111 -1 O VAL M 108 N THR M 126 SHEET 5 MA 8 VAL M 139 SER M 145 -1 N PHE M 140 O VAL M 109 SHEET 6 MA 8 ASN M 18 LEU M 27 -1 O VAL M 24 N VAL M 144 SHEET 7 MA 8 ARG M 8 ILE M 15 -1 O VAL M 9 N MET M 25 SHEET 8 MA 8 VAL M 168 GLU M 175 -1 O VAL M 169 N THR M 14 SHEET 1 OA 8 ARG O 66 ILE O 68 0 SHEET 2 OA 8 MET O 72 GLY O 75 -1 O MET O 72 N ILE O 68 SHEET 3 OA 8 PHE O 123 THR O 126 -1 O PHE O 123 N GLY O 75 SHEET 4 OA 8 VAL O 108 MET O 111 -1 O VAL O 108 N THR O 126 SHEET 5 OA 8 VAL O 139 SER O 145 -1 N PHE O 140 O VAL O 109 SHEET 6 OA 8 ASN O 18 LEU O 27 -1 O VAL O 24 N VAL O 144 SHEET 7 OA 8 ARG O 7 ILE O 15 -1 O ARG O 7 N LEU O 27 SHEET 8 OA 8 VAL O 168 GLU O 175 -1 O VAL O 169 N THR O 14 LINK C DAL B 1 N MLE B 2 1555 1555 1.34 LINK N DAL B 1 C ALA B 11 1555 1555 1.33 LINK C MLE B 2 N MLE B 3 1555 1555 1.33 LINK C MLE B 3 N MVA B 4 1555 1555 1.33 LINK C MVA B 4 N BMT B 5 1555 1555 1.33 LINK C BMT B 5 N ABA B 6 1555 1555 1.33 LINK C ABA B 6 N SAR B 7 1555 1555 1.34 LINK C SAR B 7 N MLE B 8 1555 1555 1.33 LINK C MLE B 8 N VAL B 9 1555 1555 1.33 LINK C VAL B 9 N MLE B 10 1555 1555 1.33 LINK C MLE B 10 N ALA B 11 1555 1555 1.33 LINK C DAL D 1 N MLE D 2 1555 1555 1.33 LINK N DAL D 1 C ALA D 11 1555 1555 1.33 LINK C MLE D 2 N MLE D 3 1555 1555 1.33 LINK C MLE D 3 N MVA D 4 1555 1555 1.33 LINK C MVA D 4 N BMT D 5 1555 1555 1.33 LINK C BMT D 5 N ABA D 6 1555 1555 1.33 LINK C ABA D 6 N SAR D 7 1555 1555 1.33 LINK C SAR D 7 N MLE D 8 1555 1555 1.34 LINK C MLE D 8 N VAL D 9 1555 1555 1.32 LINK C VAL D 9 N MLE D 10 1555 1555 1.33 LINK C MLE D 10 N ALA D 11 1555 1555 1.33 LINK C DAL F 1 N MLE F 2 1555 1555 1.33 LINK N DAL F 1 C ALA F 11 1555 1555 1.33 LINK C MLE F 2 N MLE F 3 1555 1555 1.33 LINK C MLE F 3 N MVA F 4 1555 1555 1.33 LINK C MVA F 4 N BMT F 5 1555 1555 1.33 LINK C BMT F 5 N ABA F 6 1555 1555 1.33 LINK C ABA F 6 N SAR F 7 1555 1555 1.33 LINK C SAR F 7 N MLE F 8 1555 1555 1.33 LINK C MLE F 8 N VAL F 9 1555 1555 1.32 LINK C VAL F 9 N MLE F 10 1555 1555 1.33 LINK C MLE F 10 N ALA F 11 1555 1555 1.33 LINK C DAL H 1 N MLE H 2 1555 1555 1.33 LINK N DAL H 1 C ALA H 11 1555 1555 1.33 LINK C MLE H 2 N MLE H 3 1555 1555 1.33 LINK C MLE H 3 N MVA H 4 1555 1555 1.34 LINK C MVA H 4 N BMT H 5 1555 1555 1.34 LINK C BMT H 5 N ABA H 6 1555 1555 1.33 LINK C ABA H 6 N SAR H 7 1555 1555 1.33 LINK C SAR H 7 N MLE H 8 1555 1555 1.33 LINK C MLE H 8 N VAL H 9 1555 1555 1.33 LINK C VAL H 9 N MLE H 10 1555 1555 1.33 LINK C MLE H 10 N ALA H 11 1555 1555 1.33 LINK C DAL J 1 N MLE J 2 1555 1555 1.33 LINK N DAL J 1 C ALA J 11 1555 1555 1.33 LINK C MLE J 2 N MLE J 3 1555 1555 1.33 LINK C MLE J 3 N MVA J 4 1555 1555 1.33 LINK C MVA J 4 N BMT J 5 1555 1555 1.34 LINK C BMT J 5 N ABA J 6 1555 1555 1.33 LINK C ABA J 6 N SAR J 7 1555 1555 1.33 LINK C SAR J 7 N MLE J 8 1555 1555 1.33 LINK C MLE J 8 N VAL J 9 1555 1555 1.33 LINK C VAL J 9 N MLE J 10 1555 1555 1.33 LINK C MLE J 10 N ALA J 11 1555 1555 1.32 LINK C DAL L 1 N MLE L 2 1555 1555 1.34 LINK N DAL L 1 C ALA L 11 1555 1555 1.33 LINK C MLE L 2 N MLE L 3 1555 1555 1.33 LINK C MLE L 3 N MVA L 4 1555 1555 1.33 LINK C MVA L 4 N BMT L 5 1555 1555 1.33 LINK C BMT L 5 N ABA L 6 1555 1555 1.33 LINK C ABA L 6 N SAR L 7 1555 1555 1.34 LINK C SAR L 7 N MLE L 8 1555 1555 1.33 LINK C MLE L 8 N VAL L 9 1555 1555 1.33 LINK C VAL L 9 N MLE L 10 1555 1555 1.33 LINK C MLE L 10 N ALA L 11 1555 1555 1.32 LINK C DAL N 1 N MLE N 2 1555 1555 1.33 LINK N DAL N 1 C ALA N 11 1555 1555 1.33 LINK C MLE N 2 N MLE N 3 1555 1555 1.33 LINK C MLE N 3 N MVA N 4 1555 1555 1.34 LINK C MVA N 4 N BMT N 5 1555 1555 1.33 LINK C BMT N 5 N ABA N 6 1555 1555 1.33 LINK C ABA N 6 N SAR N 7 1555 1555 1.33 LINK C SAR N 7 N MLE N 8 1555 1555 1.34 LINK C MLE N 8 N VAL N 9 1555 1555 1.32 LINK C VAL N 9 N MLE N 10 1555 1555 1.33 LINK C MLE N 10 N ALA N 11 1555 1555 1.33 LINK C DAL P 1 N MLE P 2 1555 1555 1.33 LINK N DAL P 1 C ALA P 11 1555 1555 1.33 LINK C MLE P 2 N MLE P 3 1555 1555 1.33 LINK C MLE P 3 N MVA P 4 1555 1555 1.34 LINK C MVA P 4 N BMT P 5 1555 1555 1.33 LINK C BMT P 5 N ABA P 6 1555 1555 1.33 LINK C ABA P 6 N SAR P 7 1555 1555 1.33 LINK C SAR P 7 N MLE P 8 1555 1555 1.34 LINK C MLE P 8 N VAL P 9 1555 1555 1.33 LINK C VAL P 9 N MLE P 10 1555 1555 1.33 LINK C MLE P 10 N ALA P 11 1555 1555 1.33 SITE 1 AC1 12 ARG A 66 PHE A 71 GLN A 74 GLY A 83 SITE 2 AC1 12 ALA A 112 ASN A 113 LYS A 114 GLN A 122 SITE 3 AC1 12 PHE A 124 HIS A 132 HIS A 137 HOH B2001 SITE 1 AC2 14 ARG C 66 PHE C 71 GLN C 74 GLY C 83 SITE 2 AC2 14 ALA C 112 ASN C 113 LYS C 114 GLN C 122 SITE 3 AC2 14 PHE C 124 HIS C 132 HIS C 137 HOH C2023 SITE 4 AC2 14 HOH D2001 HOH D2003 SITE 1 AC3 12 ARG E 66 PHE E 71 GLN E 74 GLY E 83 SITE 2 AC3 12 ALA E 112 ASN E 113 LYS E 114 GLN E 122 SITE 3 AC3 12 PHE E 124 HIS E 132 HIS E 137 HOH F2001 SITE 1 AC4 19 MET E 46 ALA E 47 ILE E 89 HOH E2016 SITE 2 AC4 19 ARG G 66 PHE G 71 GLN G 74 GLY G 83 SITE 3 AC4 19 ALA G 112 ASN G 113 LYS G 114 GLN G 122 SITE 4 AC4 19 PHE G 124 HIS G 132 HIS G 137 HOH H2001 SITE 5 AC4 19 HOH H2002 HIS O 132 ILE O 136 SITE 1 AC5 12 ARG I 66 PHE I 71 GLN I 74 GLY I 83 SITE 2 AC5 12 ALA I 112 ASN I 113 LYS I 114 GLN I 122 SITE 3 AC5 12 PHE I 124 HIS I 132 HIS I 137 HOH J2002 SITE 1 AC6 19 MET C 46 ALA C 47 ILE C 89 ARG K 66 SITE 2 AC6 19 PHE K 71 GLN K 74 GLY K 83 ALA K 112 SITE 3 AC6 19 ASN K 113 LYS K 114 GLN K 122 PHE K 124 SITE 4 AC6 19 HIS K 132 HIS K 137 HOH K2038 HOH L2002 SITE 5 AC6 19 HOH L2003 HIS M 132 ILE M 136 SITE 1 AC7 15 ARG C 34 HIS K 132 ILE K 136 ARG M 66 SITE 2 AC7 15 PHE M 71 GLN M 74 GLY M 83 ALA M 112 SITE 3 AC7 15 ASN M 113 LYS M 114 GLN M 122 PHE M 124 SITE 4 AC7 15 HIS M 132 HIS M 137 HOH N2001 SITE 1 AC8 14 ARG E 34 TYR E 90 HIS G 132 ARG O 66 SITE 2 AC8 14 PHE O 71 GLN O 74 GLY O 83 ALA O 112 SITE 3 AC8 14 ASN O 113 LYS O 114 GLN O 122 PHE O 124 SITE 4 AC8 14 HIS O 132 HIS O 137 CRYST1 62.000 100.160 133.920 90.00 93.75 90.00 P 1 21 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016129 0.000000 0.001057 0.00000 SCALE2 0.000000 0.009984 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007483 0.00000